12:00 AM
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

EHT Dx14 diagnostic data

The second phase of a validation study evaluating 55 breast tissue fine needle aspirate (FNA) samples for which cytological analysis gave indeterminate results showed that EHT Dx14 had 81.8% specificity and 77.3% sensitivity for differentiating benign from malignant breast tumors. A post hoc analysis...

Read the full 196 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >